Nike Suspends Maria Sharapova After Failed Drug Test Admission!

Some of the links in this post are affiliate links, which means if you click on the link and purchase an item, I will receive an affiliate commission at no extra cost to you.

09/05/2013 - Maria Sharapova - 3.1 Phillip Lim for Target Launch Event - Arrivals - Spring Studio - New York City, NY, USA - Keywords: Launch Party, Fashion Week, Target Event, New York City, Celebrities, Arrivals Orientation: Portrait Face Count: 1 - False - Photo Credit: Marco Sagliocco / - Contact (1-866-551-7827) - Portrait Face Count: 1

Nike has decided to suspend their contract with tennis star, Maria Sharapova following her admission of using a banned substance. Nike released a statement,  “We are saddened and surprised by the news about Maria Sharapova. We have decided to suspend our relationship with Maria while the investigation continues. We will continue to monitor the situation.”

Just yesterday the 28-year-old athlete admitted to failing a drug test before the Australian Open. “I did fail the test and I take full responsibility for it. I was getting sick very often, I had a deficiency of magnesium, irregular EKG results, family history of diabetes — and that’s one of the medications, along with several others that I had received. I made a huge mistake. I let my fans down. I let the sport down that I’ve been playing since the age of 4, that I love so deeply. I know that with this I face consequences and I don’t want to end my career this way. I really hope to be given another chance to play this game.”

Maria says she never clicked the email from the WADA about the new list of banned substances. “I received an email on 22 December from WADA [World Anti-Doping Agency] about the changes happening to the banned list and you can see prohibited items, and I didn’t click on that link.”

The drug Meldonium had been legal but was banned this year and Sharapova says she was unaware of the change. Porsche and Tag Hauer have also suspended the athlete!

Photo from PR Photos

Privacy Policy